Effect of age and neuroleptics on tyrosine hydroxylase-IR in sector CA2 of schizophrenic brain

NeuroReport

Volumn 10, Issue 17, 1999, Pages 3527-3530

  Benes, Francine M ^a,b   Todtenkopf, Mark S ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotics; Dopamine; Neurodevelopment; Onset of schizophrenia; Sector CA2; Trisynaptic pathway

Indexed keywords

CHLORPROMAZINE; DOPAMINE; NEUROLEPTIC AGENT; TYROSINE 3 MONOOXYGENASE;

ADULT; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE PROJECTION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPIL; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

EID: 0033607441     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911260-00012     Document Type: Article

References (27)

1. 1. Benes FM, Kwok EW, Vincent SL and Todtenkopf MS. Biol Psychiatry 44, 88-97 (1998).
2. 2. Benes FM, Khan Y, Vincent SL and Wickramasinghe R. Synapse 22, 338-349 (1996).
3. 3. Benes FM, Wickramasinghe R, Vincent SL et al. Brain Res 755, 121-129 (1997).
4. 4. Todtenkopf MS and Benes FM. Synapse 29, 323-332 (1998).
5. 5. Kostoulakos P, Todtenkopf MS and Benes FM. Soc Neurosc Abstr 24, 505.10 (1998).
6. 6. Benes FM, McSparren J, Bird ED et al. Arch Gen Pyschiatry 48, 996-1001 (1991).
7. 7. Benes FM, Vincent SL, Alsterberg G et al. J Neurosci 12, 924-929 (1992).
8. 8. Benes FM, Sorensen I, Vincent SL et al. Cerebr Cortex 2, 502-512 (1992).
9. 9. Benes FM, Todtenkopf MS and Taylor JB. Synapse 25, 80-92 (1997).
10. 10. Verney C, Berger B, Adrien J et al. Dev Brain Res 5, 41-52 (1982).
11. 11. Kalsbeek A, Voorn P, Buijs RM et al. J Comp Neurol 269, 58-72 (1988).
12. 12. Benes FM, Vincent SL, Molloy R and Khan Y. Synapse 23, 237-245 (1996).
13. 13. Benes FM. J Psychiatric Res 31, 257-275 (1997).
14. 14. Akil M and Lewis DA. Cerebr Cortex 3, 533-550 (1993).
15. 15. Gaspar P, Berger B, Febvret A et al. J Comp Neurol 279, 249-71 (1989).
16. 16. Lewis DA, Campbell MJ, Foote SL et al. J Neurosci 7, 279-290 (1987).
17. 17. Noack HJ and Lewis DA. Brain Res 500, 313-324 (1989).
18. 18. Samson Y, Wu JJ, Friedman AH and Davis JN. J Comp Neurol 298, 250-263 (1990).
19. 19. Williams SM and Goldman-Rakic PS. Cerebr Cortex 3, 199-222(1993).
20. 20. Feighner JP, Robins E and Guze SB. Arch Gen Psychiatry 26, 57-63 (1972).
21. 21. Benes FM. Psychiat Dev 6, 213-226 (1988).
22. 22. Smith JM and Baldessarini RJ. Arch Gen Psychiatry 37, 1367-1373 (1980).
23. 23. Thierry AM, Tassin JP, Blanc G and Glowinski J. Nature 262, 242-244 (1976).
24. 24. Roth R, Tam SY, Ida Y et al. Ann NY Acad Sci 537, 138-147 (1988).
25. 25. Carlsson A. Am J Psychiatry 135, 164-173 (1978).
26. 26. Rosene DK and Van Hoesen GW. The hippocampal formation of the primate brain: a review of some comparative aspects of cytoarchitecture and connections. In: Jones EG and Peters A, eds. Cerebral Cortex Vol. 6. Further Aspects of Cortical Function, Including Hippocampus. New York: Plenum Press, 1987: 345-356.
27. 27. Heckers S, Rausch SL, Goff D et al. Nature Neurosci 1, 318-323 (1998).